Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Efficacy Remaining at Time of Requested Retreatment Following Botulinum Toxin Treatment for Cervical dystonia: Potential for a New Treatment Paradigm with DaxibotulinumtoxinA

              Author:Ellenbogen, Aaron   Hauser, Robert   Patel, Atul   McAllister, Peter   Vitarella, Domenico   Gross, Todd   Kazerooni, Rashid   Gallagher, Conor   Hollander, David   

              Session Name:P1: Movement Disorders: Dystonia 1  

              Topic:Movement Disorders  

              Program Number:P1.015  

              Author Institution:Michigan Institute for Neurological Disorders, Farmington Hills, MI  Movement Disorders Center, Tampa, FL  Kansas City Bone & Joint Clinic, Kansas City, KS  New England Inst for Neurology and Headache, Stamford, CT  Revance Therapeutics Inc, Newark, CA  

              EMERGE Study: An Open-label Evaluation of the Efficacy and Safety of AXS-07 (MoSEIC™ meloxicam-rizatriptan) for Migraine in Adults with Prior Inadequate Response to an Oral CGRP Inhibitor

              Author:McAllister, Peter   Tepper, Stewart   Chhabra, Angad   Streicher, Caroline   Parks, Gregory   Tabuteau, Herriot   

              Session Name:P6: Headache: Therapeutics 1  

              Topic:Headache  

              Program Number:P6.006  

              Author Institution:New England Inst for Neurology and Headache, Stamford, CT  Geisel School of Medicine At Dartmouth, Lebanon, NH  Axsome Therapeutics, New York, NY  Axsome Therapeutics, Fair Lawn, NJ  Axsome Therapeutics, Redwood City, CA